Summit plc

By Business Review Editor

PharmaDeals Review: Vol 2008 Issue 92 (Table of Contents)

Published: 8 Feb-2008

DOI: 10.3833/pdr.v2008i92.226     ISSN: 1756-7874

Section: General

Fulltext:

Abstract

Summit is a biotechnology company that developed very rapidly and was listed on the AIM segment of the London Stock Exchange...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login on the top right purple box.

Copyright: PharmaVentures Ltd

Bookmarks

Bookmark PharmaDeals through one of these social networks.